Exactus (EXDI) Stock Price, News & Analysis

Company Overview

Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 257,300 shs
• Average Volume: 83,144 shs
• Market Capitalization: $38.94 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EXDI Stock Analysis - Frequently Asked Questions

When did Exactus' stock split?

Exactus's stock reverse split before market open on Thursday, October 28th 2021.The 1-28 reverse split was announced on Thursday, October 28th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 28th 2021. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

How do I buy shares of Exactus?

Shares of EXDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Exactus own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Exactus investors own include Fulcrum Therapeutics (FULC), Ashford Hospitality Trust (AHT), Assertio (ASRT), Peabody Energy (BTU), PlayAGS (AGS), Astronics (ATRO) and Aytu BioPharma (AYTU).

Company Calendar

• Today: 8/31/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medicinals & Botanicals
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:EXDI
• CIK: 1552189
• Web: www.exactusinc.com
• Phone: 804-205-5036
• Fax: N/A
• Employees: 30
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$9.46 million
• Net Margins: N/A
• Pretax Margin: -15,131.74%
• Return on Equity: -3,272.69%
• Return on Assets: -185.29%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.32
• Quick Ratio: 0.82

Sales & Book Value

• Annual Sales: $2.07 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.09) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 599,005,000
• Free Float: 209,652,000
• Market Cap: $38.94 million
• Optionable: Not Optionable
• Beta: 4.21